Table 6. Comparison of tumors expressing high and low levels of Shh in TNBC patients.

		n	HR (95% CI)	5-year survival (%)	Med. survival (95%CI)	p-values
	High	61		40	20 months (1.10–1.46)
Shh			3.29(1.42–5.53)			0.002
	Low	42		65	72 months (0.95–1.11)